- Home
- ALT vs TRAK Comparison
ALT vs TRAK Comparison
Compare ALT & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- TRAK
- Stock Information
- Founded
- ALT 1997
- TRAK 1990
- Country
- ALT United States
- TRAK United States
- Employees
- ALT N/A
- TRAK N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- TRAK EDP Services
- Sector
- ALT Health Care
- TRAK Technology
- Exchange
- ALT Nasdaq
- TRAK Nasdaq
- Market Cap
- ALT 327.4M
- TRAK 374.5M
- IPO Year
- ALT N/A
- TRAK 1998
- Fundamental
- Price
- ALT $3.59
- TRAK $17.24
- Analyst Decision
- ALT Strong Buy
- TRAK
- Analyst Count
- ALT 6
- TRAK 0
- Target Price
- ALT $17.40
- TRAK N/A
- AVG Volume (30 Days)
- ALT 2.4M
- TRAK 49.1K
- Earning Date
- ALT 11-11-2025
- TRAK 11-13-2025
- Dividend Yield
- ALT N/A
- TRAK 0.47%
- EPS Growth
- ALT N/A
- TRAK 21.41
- EPS
- ALT N/A
- TRAK 0.34
- Revenue
- ALT $20,000.00
- TRAK $22,028,373.00
- Revenue This Year
- ALT N/A
- TRAK $15.18
- Revenue Next Year
- ALT $761,880.20
- TRAK $10.00
- P/E Ratio
- ALT N/A
- TRAK $50.25
- Revenue Growth
- ALT N/A
- TRAK 9.73
- 52 Week Low
- ALT $2.90
- TRAK $15.12
- 52 Week High
- ALT $11.16
- TRAK $25.01
- Technical
- Relative Strength Index (RSI)
- ALT 45.32
- TRAK 54.46
- Support Level
- ALT $3.54
- TRAK $16.86
- Resistance Level
- ALT $3.72
- TRAK $17.39
- Average True Range (ATR)
- ALT 0.16
- TRAK 0.44
- MACD
- ALT 0.02
- TRAK 0.13
- Stochastic Oscillator
- ALT 21.87
- TRAK 91.25
About ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About TRAK ReposiTrak Inc.
ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.